Business Context and Reporting Period
Company: SeaStar Medical Holding Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: April 12, 2024
Reporting Period: Event-specific (April 12, 2024 Board Action)
This filing reports corporate governance amendments approved by the Board of Directors. The Company is an emerging growth company incorporated in Delaware with principal executive offices in Denver, Colorado.
Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
The Board approved the amendment and restatement of the Company's Bylaws (Second Amended and Restated Bylaws) with the following material changes:
- Quorum Threshold Reduction: The quorum requirement for stockholder meetings was reduced from a majority (50% + 1) of issued and outstanding common stock to at least 33 1/3% of issued and outstanding common stock entitled to vote.
- Removal of "Acting in Concert" Provisions: The definition and provisions regarding "Acting in Concert" in Sections 2.12(a) and 2.12(b) were removed. Consequently, a Proposing Stockholder no longer includes a person acting in concert with another stockholder or beneficial owner.
Guidance, Outlook, and Risks
Management Commentary: The filing focuses solely on the procedural changes to the Bylaws. No forward-looking guidance, operational outlook, or management commentary regarding business performance is included.
Risks and Contingencies: No specific risks or contingencies are disclosed in this filing. The summary of the Bylaws is qualified by reference to the full text attached as Exhibit 3.1.
Key Facts for Investor Verification
- Verify the full text of the Second Amended and Restated Bylaws in Exhibit 3.1 to understand the complete scope of the governance changes.
- Confirm the impact of the reduced quorum threshold (33 1/3%) on the ability to conduct stockholder meetings and pass resolutions.
- Assess how the removal of the "Acting in Concert" definition may affect stockholder proposals and proxy contests.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial performance.